Impact Biomedicines, Inc. logo

Impact Biomedicines, Inc.

Impact Biomedicines, Inc. engages in the development of cancer treatments. It engages in the development of fedratinib, a potent and highly selective oral small molecule JAK2 kinase inhibitor for the treatment of myelofibrosis and polycythemia vera.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://impactbiomedicines.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
12526 High Bluff Drive, Suite 260,CA 092130
San Diego
United States
Email
Contact Number
+1 858-221-0950

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/impactbiomedicines” connections=”true” suffix=””]